<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Chinese Medicine - Latest articles</title>
		<link>http://www.cmjournal.org</link>
		<description>The latest articles from Chinese Medicine (ISSN 1749-8546) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.cmjournal.org/content/3/1/5"/>			    
            
				    <rdf:li rdf:resource="http://www.cmjournal.org/content/3/1/4"/>			    
            
				    <rdf:li rdf:resource="http://www.cmjournal.org/content/3/1/3"/>			    
            
				    <rdf:li rdf:resource="http://www.cmjournal.org/content/3/1/2"/>			    
            
				    <rdf:li rdf:resource="http://www.cmjournal.org/content/3/1/1"/>			    
            
				    <rdf:li rdf:resource="http://www.cmjournal.org/content/2/1/13"/>			    
            
				    <rdf:li rdf:resource="http://www.cmjournal.org/content/2/1/12"/>			    
            
				    <rdf:li rdf:resource="http://www.cmjournal.org/content/2/1/11"/>			    
            
				    <rdf:li rdf:resource="http://www.cmjournal.org/content/2/1/10"/>			    
            
				    <rdf:li rdf:resource="http://www.cmjournal.org/content/2/1/9"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.cmjournal.org/content/3/1/5">
            
            <title>Simultaneous determination of eight major bioactive compounds in Dachengqi Tang (DT) by high-performance liquid chromatography</title>
			<description>Background:
Dachengqi Tang (DT) is a common traditional Chinese medicine formula for expelling neire ('internal heat') in the stomach and intestines. There was no reliable analytical method available for the quality control of DT. 
Methods:
A high-performance liquid chromatography (HPLC) method with a reverse phase C18 column (150 x 4.6mm) was developed. The mobile phase was methanol with 0.2% acetic acid. Eight markers including naringin, hesperidin, aloe emodin, rhein, honokiol, magnolol, emodin and chrysophanol were determined. 
Results:
Regression analysis revealed a linear relationship between the concentrations of the markers and the peak area ratio of the standards and internal standard. The limit of detection (S/N=3) and the limit of qualification (RSD&lt;20%) ranged from 0.21 to 0.43 ng/ul and 0.76 to 1.74 ng/ul respectively. The recovery was between 95.6% and 103.4%. The tests on the samples from three batches of DT showed that the profiles of the markers did not vary significantly among batches. 
Conclusion:
A reliable HPLC method for simultaneous determination of the eight markers in DT was developed.</description>
			<link>http://www.cmjournal.org/content/3/1/5</link>
			
			 	<dc:creator>Wenfu Tang, Meihua Wan, Zhengyan Zhu, Guanyuan Chen and Xi Huang</dc:creator>
			
			<dc:source>Chinese Medicine 2008, 3:5</dc:source>
			<dc:date>2008-04-29</dc:date>
			<dc:identifier>doi:10.1186/1749-8546-3-5</dc:identifier>
			
			
							
					<prism:publicationName>Chinese Medicine</prism:publicationName>
					
			
							
					<prism:issn>1749-8546</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>5</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.cmjournal.org/content/3/1/4">
            
            <title>Chinese red yeast rice (Monascus purpureus-fermented rice) promotes bone formation</title>
			<description>Background:
Statin can induce the gene expression of bone morphogenetic protein-2. Red yeast rice (RYR, Hongqu), i.e. rice fermented with Monascus purpureus, contains a natural form of statin. This study demonstrates the effects of RYR extract on bone formation.
Methods:
Bone defects were created in the parietal bones of two New Zealand white rabbits. In the test animal, two defects were grafted with collagen matrix mixed with RYR extract. In the control animal, two defects were grafted with collagen matrix alone. UMR 106 cell line was used to test RYR extract in vitro. In the control group, cells were cultured for three durations (24 hours, 48 hours and 72 hours) without any intervention. In the RYR group, cells were cultured for the same durations with various concentrations of RYR extract (0.001 g/ml, 0.005 g/ml and 0.01 g/ml). Bicinchoninic acid (BCA) assay, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and alkaline phosphatase (ALP) assay were performed to measure total protein, mitochondrial activity and bone cell formation respectively.
Results:
The test animal showed more formation of new bone in the defects than the control animal. RYR significantly increased the optical density in the MTT assay and ALP activity in vitro.
Conclusion:
RYR extract stimulated new bone formation in bone defects in vivo and increased bone cell formation in vitro.</description>
			<link>http://www.cmjournal.org/content/3/1/4</link>
			
			 	<dc:creator>Ricky WK Wong and Bakr Rabie</dc:creator>
			
			<dc:source>Chinese Medicine 2008, 3:4</dc:source>
			<dc:date>2008-03-29</dc:date>
			<dc:identifier>doi:10.1186/1749-8546-3-4</dc:identifier>
			
			
							
					<prism:publicationName>Chinese Medicine</prism:publicationName>
					
			
							
					<prism:issn>1749-8546</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>4</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.cmjournal.org/content/3/1/3">
            
            <title>Metabolic profiling reveals therapeutic effects of Herba Cistanches in an animal model of hydrocortisone-induced 'kidney-deficiency syndrome'</title>
			<description>Background:
Herba Cistanches (Roucongrong) is effective in treating Shenxu Zheng ('kidney-deficiency syndrome'). However, the mechanisms and systemic metabolic responses to the herbal intervention are unclear.
Methods:
Using GC-MS-based metabolic profiling, we investigated the metabolic responses to Herba Cistanches intervention in a rat model of the hydrocortisone-induced 'kidney-deficiency syndrome'.
Results:
The metabolic profiles of the rats after hydrocortisone injection deviated from the pre-dose metabolic state at different time points, ranging from day 1 to day 10, whereas the metabolic profiles of the rats treated with both hydrocortisone and water extract of Herba Cistanches returned to the pre-dose state on day 10.
Conclusion:
The intervention of Herba Cistanches caused a systemic recovery from the hydrocortisone-induced metabolic perturbation in rats. This study also demonstrates that metabolic profiling is useful in studying therapeutic mechanisms of herbal medicines.</description>
			<link>http://www.cmjournal.org/content/3/1/3</link>
			
			 	<dc:creator>Yunping Qiu, Minjun Chen, Mingming Su, Guoxiang Xie, Xin Li, Mingmei Zhou, Aihua Zhao, Jian Jiang and Wei Jia</dc:creator>
			
			<dc:source>Chinese Medicine 2008, 3:3</dc:source>
			<dc:date>2008-03-10</dc:date>
			<dc:identifier>doi:10.1186/1749-8546-3-3</dc:identifier>
			
			
							
					<prism:publicationName>Chinese Medicine</prism:publicationName>
					
			
							
					<prism:issn>1749-8546</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>3</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-03-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.cmjournal.org/content/3/1/2">
            
            <title>A pilot study on using acupuncture and transcutaneous electrical nerve stimulation (TENS) to treat knee osteoarthritis (OA)</title>
			<description>Background:
The present study tests whether a combined treatment of acupuncture and transcutaneous electrical nerve stimulation (TENS) is more effective than acupuncture or TENS alone for treating knee osteoarthritis (OA).
Methods:
Thirty-two patients with knee OA were randomly allocated to four groups. The acupuncture group (ACP) received only acupuncture treatment at selected acupoints for knee pain; the TENS group (TENS) received only TENS treatment at pain areas; the acupuncture and TENS group (A&amp;T) received both acupuncture and TENS treatments; the control group (CT) received topical poultice (only when necessary). Each group received specific weekly treatment five times during the study. Outcome measures were pain intensity in a visual analogue scale (VAS) and knee function in terms of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).
Results:
The ACP, TENS and A&amp;T groups reported lower VAS and WOMAC scores than the control group. Significant reduction in pain intensity (P = 0.039) and significant improvement in knee function (P = 0.008) were shown in the A&amp;T group.
Conclusion:
Combined acupuncture and TENS treatment was effective in pain relief and knee function improvement for the sampled patients suffering from knee OA.</description>
			<link>http://www.cmjournal.org/content/3/1/2</link>
			
			 	<dc:creator>Kazunori Itoh, Satoko Hirota, Yasukazu Katsumi, Hideki Ochi and Hiroshi Kitakoji</dc:creator>
			
			<dc:source>Chinese Medicine 2008, 3:2</dc:source>
			<dc:date>2008-02-29</dc:date>
			<dc:identifier>doi:10.1186/1749-8546-3-2</dc:identifier>
			
			
							
					<prism:publicationName>Chinese Medicine</prism:publicationName>
					
			
							
					<prism:issn>1749-8546</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>2</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-02-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.cmjournal.org/content/3/1/1">
            
            <title>Effects of Yinchenhao Tang and related decoctions on DMN-induced cirrhosis/fibrosis in rats</title>
			<description>Background:
Chinese medicine decoctions such as Yinchenhao Tang (YCHT), Xiayuxue Tang (XYXT), Huangqi Tang (HQT), Yiguan Jian (YGJ) and Xiaochaihu Tang (XCHT)) were used to treat liver cirrhosis. The present study evaluates the effects of these decoctions on fibrosis in rats induced by dimethylnitrosamine (DMN).
Methods:
DMN solution (0.5%) was injected to rats for three consecutive days per week for four weeks. At the beginning of week 3, rats were randomly divided into 4-week DMN control group, YCHT, XYXT, HQT, YGJ, XCHT and vehicle groups. Each group was orally administered with specific decoctions daily for two weeks. Rats in the vehicle group were orally administered with only water.
Results:
Liver fibrosis and cirrhosis were observed in weeks 2 and 4 in DMN-intoxicated rats. Compared with normal rats, alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP) activities and level of total bilirubin acid (TBA) in serum and content of Hydroxyproline (Hyp) in liver tissue of model group rats rose significantly. However, the albumin (Alb) level in serum decreased significantly. Compared with the 4-week DMN group, the pathological conditions and functions of the liver in the YCHT group improved significantly, and the content of Hyp decreased remarkably: only one rat in this group developed liver cirrhosis and the ratio of cirrhosis was only 8.3%. On the other hand, the other decoctions did not show remarkable effects. YCHT inhibited &#945;-SMA activation, including its gene expression into mRNA and protein.
Conclusion:
Among the five Chinese medicine decoctions, YCHT exerted the most significant therapeutic effects on DMN-induced cirrhosis/fibrosis in rats.</description>
			<link>http://www.cmjournal.org/content/3/1/1</link>
			
			 	<dc:creator>Cheng Liu, Mingyu Sun, Lei Wang, Gaoqiang Wang, Gaofeng Chen, Chenghai Liu and Ping Liu</dc:creator>
			
			<dc:source>Chinese Medicine 2008, 3:1</dc:source>
			<dc:date>2008-01-31</dc:date>
			<dc:identifier>doi:10.1186/1749-8546-3-1</dc:identifier>
			
			
							
					<prism:publicationName>Chinese Medicine</prism:publicationName>
					
			
							
					<prism:issn>1749-8546</prism:issn>
					
			
							
					<prism:volume>3</prism:volume>
					
			
							
					<prism:startingPage>1</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-01-31</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.cmjournal.org/content/2/1/13">
            
            <title>The effects of Rhizoma Curculiginis and Rhizoma Drynariae extracts on bones</title>
			<description>Background:
Rhizoma Curculiginis (Xianmao) and Rhizoma Drynariae (Gusuibu) are 'Yang-tonifying' traditional Chinese herbal medicines used to strengthen bones. This investigation aims to assess the systemic effect of extracts of Rhizoma Curculiginis and Rhizoma Drynariae on bone histomorphology and formation, and their local effect on bone healing.
Methods:
For the investigation of the systemic effect, thirty 8-week-old male BALB/c mice were divided into three groups: (1) control group, ten mice fed daily with distilled water; (2) Rhizoma Curculiginis group, ten mice fed daily with distilled water mixed with Rhizoma Curculiginis extract; (3) Rhizoma Drynarie group, ten mice fed daily with distilled water mixed with Rhizoma Drynarie extract. The mice were fed for five weeks before sacrifice. Twenty micro-tomographic slices with an increment of 0.25 mm were prepared to cover the proximal end of the left tibia of each mouse. Quantitative morphometry of the bone structure was performed. For the investigation of the local effect on bone healing, two bone defects (5 &#215; 10 mm) were created in the parietal bone of each of the three New Zealand white rabbits. Two defects in the first animal were grafted with collagen matrix with Rhizoma Curculiginis extract; two defects in the second animal were grafted with collagen matrix with Rhizoma Drynarie extract; two defects in the third (control) animal were grafted with collagen matrix alone. The animals were sacrificed on day 14 and the defects were dissected and prepared for histological and ultrastructural assessment.
Results:
Rhizoma Curculiginis and Rhizoma Drynariae extracts altered the bone histomorphology, both increasing the trabecular number by 10% (P = 0.002). Rhizoma Curculiginis extract increased bone density by 3.13% (P = 0.122) and Rhizoma Drynariae extract increased bone density by 6.45% (P = 0.005). Both Rhizoma Curculiginis and Rhizoma Drynariae extracts induced new bone formation on the margins of the defects.
Conclusion:
Two 'Yang-tonifying' herbs, Rhizoma Curculiginis and Rhizoma Drynariae, were demonstrated to have systemic effects on bone histomorphology and formation as well as local bone healing.</description>
			<link>http://www.cmjournal.org/content/2/1/13</link>
			
			 	<dc:creator>Ricky WK Wong, Bakr Rabie, Margareta Bendeus and Urban H&#228;gg</dc:creator>
			
			<dc:source>Chinese Medicine 2007, 2:13</dc:source>
			<dc:date>2007-12-19</dc:date>
			<dc:identifier>doi:10.1186/1749-8546-2-13</dc:identifier>
			
			
							
					<prism:publicationName>Chinese Medicine</prism:publicationName>
					
			
							
					<prism:issn>1749-8546</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>13</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-12-19</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.cmjournal.org/content/2/1/12">
            
            <title>Verification of the formulation and efficacy of Danggui Buxue Tang (a decoction of Radix Astragali and Radix Angelicae Sinensis): an exemplifying systematic approach to revealing the complexity of Chinese herbal medicine formulae</title>
			<description>This article exemplifies a systematic approach to revealing the complexity of Chinese herbal medicine formulae through three levels of scientific research: standardization of herbs, verification of ancient formulae and mechanism studies. We use Danggui Buxue Tang (DBT) as an example for this approach. Among thousands of traditional Chinese medicine herbal formulae, almost all of which consist of multiple herbs, DBT is one of the simplest. Containing only two herbs, namely Radix Astragali (RA) and Radix Angelicae Sinensis (RAS), DBT is traditionally used to treat ailments in women. The weight ratio of RA to RAS in DBT was prescribed to be 5:1 as early as in 1247 AD. In addition to advanced chemical analysis of herbal constituents, DNA genotyping techniques have been developed for reliable standardization of RA and RAS. Chemical evaluation shows that main active constituents in DBT, including astragaloside IV, calycosin, formononetin and ferulic acid, were most abundant after extraction at the RA to RAS ratio of 5:1, whereas other tested RA to RAS ratios only gave sub-optimal levels of the active constituents. Biological evaluation indicates that bioactivities of DBT, e.g. immuno-modulatory, oesteotropic and estrogenic effects are also best exerted at the RA to RAS ratio of 5:1. Correlation analysis demonstrates statistically significant relationship between the tested chemical constituents and tested bioactivities. Up- and down-regulation of expression of some genes as potential biomarkers has been detected by using gene chip technology. This systematic approach on the basis of herbal standardization, chemical and biological verification and mechanism studies, as exemplified in this article, will be useful to reveal the complexity of not only DBT but also other Chinese medicine herbal formulae.</description>
			<link>http://www.cmjournal.org/content/2/1/12</link>
			
			 	<dc:creator>Qiutao Gao, Jun Li, Jerry Ka Hei Cheung, Jinao Duan, Anwei Ding, Anna Wing Han Cheung, Kuijun Zhao, Winnie Zhuoming Li, Tina Tingxia Dong and Karl Wah Keung Tsim</dc:creator>
			
			<dc:source>Chinese Medicine 2007, 2:12</dc:source>
			<dc:date>2007-11-29</dc:date>
			<dc:identifier>doi:10.1186/1749-8546-2-12</dc:identifier>
			
			
							
					<prism:publicationName>Chinese Medicine</prism:publicationName>
					
			
							
					<prism:issn>1749-8546</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>12</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-11-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.cmjournal.org/content/2/1/11">
            
            <title>American ginseng modulates pancreatic beta cell activities</title>
			<description>The mechanism of the beneficial effects of Panax quinquefolius (Xiyangshen, American ginseng) on diabetes is yet to be elucidated. Recent studies show that Panax quinquefolius increases insulin production and reduces the death of pancreatic beta cells. Mechanism studies indicate that Panax quinquefolius improves cell's immuno-reactivity and mitochondrial function through various factors. Clinical studies show that Panax quinquefolius improves postprandial glycemia in type 2 diabetic patients. Further studies to identify the component(s) of Panax quinquefolius linked with pancreatic islets/beta cells in vitro and in vivo are warranted for better understanding of the full effects of Panax quinquefolius.</description>
			<link>http://www.cmjournal.org/content/2/1/11</link>
			
			 	<dc:creator>Zonggui Wu, John Zeqi Luo and Luguang Luo</dc:creator>
			
			<dc:source>Chinese Medicine 2007, 2:11</dc:source>
			<dc:date>2007-10-25</dc:date>
			<dc:identifier>doi:10.1186/1749-8546-2-11</dc:identifier>
			
			
							
					<prism:publicationName>Chinese Medicine</prism:publicationName>
					
			
							
					<prism:issn>1749-8546</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>11</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-10-25</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.cmjournal.org/content/2/1/10">
            
            <title>Effect of an herbal extract Number Ten (NT) on body weight in rats</title>
			<description>Background:
Chinese herbal extract Number Ten (NT) is a dietary herbal formulation prepared from rhubarb, ginger, astragalus, red sage and tumeric. This study tested the effectiveness of NT in reducing body weight gain in rats.
Methods:
Sixty female Wistar rats were fed a high fat diet and acclimated to gavage feeding. The rats were divided into five treatment groups: (1) Control (n = 15); (2) NT-H (n = 15), 1.5 g/day; (3) NT-L (n = 10), 0.75 g/day; (4) Pr-fed (n = 10), pair fed to NT-H; (5) d-FF (n = 10), d-fenfluramine 2 mg/kg. Ten rats per group were sacrificed on day 56. Weight, food intake, clinical chemistry and body composition were evaluated. Five animals in the control and 1.5 g/day NT groups were left untreated during a two week recovery period.
Results:
The 0.75 g/day NT, 1.5 g/day NT, d-fenfluramine and pair fed groups gained 24.6%, 33.3%, 12.3% and 33.3% less than the control respectively (P &lt; 0.0006). Leptin decreased 27.5% to 46.2% in the treatment groups vs. control (P &lt; 0.009). Parametrial fat decreased 14.1% to 55.5% in the NT and pair fed groups vs. control (P &lt; 0.006). The NT groups had soft stools, loss of hair around the mouth and coloration to the urine and stool without evidence of blood or bilirubin (attributed to chromogens in NT). There were no differences between groups in the clinical chemistry.
Conclusion:
This study demonstrated the efficacy of NT in reducing weight gain in rodents.</description>
			<link>http://www.cmjournal.org/content/2/1/10</link>
			
			 	<dc:creator>David A York, Sonyja Thomas, Frank L Greenway, Zhijun Liu and Jennifer C Rood</dc:creator>
			
			<dc:source>Chinese Medicine 2007, 2:10</dc:source>
			<dc:date>2007-09-14</dc:date>
			<dc:identifier>doi:10.1186/1749-8546-2-10</dc:identifier>
			
			
							
					<prism:publicationName>Chinese Medicine</prism:publicationName>
					
			
							
					<prism:issn>1749-8546</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>10</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-09-14</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.cmjournal.org/content/2/1/9">
            
            <title>DNA methods for identification of Chinese medicinal materials</title>
			<description>As adulterated and substituted Chinese medicinal materials are common in the market, therapeutic effectiveness of such materials cannot be guaranteed. Identification at species-, strain- and locality-levels, therefore, is required for quality assurance/control of Chinese medicine. This review provides an informative introduction to DNA methods for authentication of Chinese medicinal materials. Technical features and examples of the methods based on sequencing, hybridization and polymerase chain reaction (PCR) are described and their suitability for different identification objectives is discussed.</description>
			<link>http://www.cmjournal.org/content/2/1/9</link>
			
			 	<dc:creator>Pui Ying Yip, Chi Fai Chau, Chun Yin Mak and Hoi Shan Kwan</dc:creator>
			
			<dc:source>Chinese Medicine 2007, 2:9</dc:source>
			<dc:date>2007-09-05</dc:date>
			<dc:identifier>doi:10.1186/1749-8546-2-9</dc:identifier>
			
			
							
					<prism:publicationName>Chinese Medicine</prism:publicationName>
					
			
							
					<prism:issn>1749-8546</prism:issn>
					
			
							
					<prism:volume>2</prism:volume>
					
			
							
					<prism:startingPage>9</prism:startingPage>
					
			
							
					<prism:publicationDate>2007-09-05</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
